Other
Common Stock, Shares, Outstanding
Vertex Pharmaceuticals Common Stock, Shares, Outstanding increased by 0.1% to 254.2M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.1%, from 257M to 254.2M. Over 5 years (FY 2020 to FY 2025), Common Stock, Shares, Outstanding shows relatively stable performance with a -0.5% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2015
Last reportedQ1 2026May 5, 2026
How to read this metric
A decrease indicates share buybacks, which can boost EPS, while an increase suggests equity issuance, which may dilute existing shareholders.
Detailed definition
This is the total number of common shares held by all shareholders, excluding treasury shares. It is the primary denomin...
Peer comparison
Standardized metric used globally to assess equity dilution and ownership structure.
Metric ID:
other_common_stock_shares_outstandingHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 259.1M | 256.2M | 254.5M | 255.6M | 256M | 256.6M | 257M | 257.5M | 257.8M | 257.8M | 257.7M | 258.3M | 258M | 257.7M | 256.9M | 257M | 256.3M | 254M | 254M | 254.2M |
| QoQ Change | — | -1.1% | -0.7% | +0.4% | +0.2% | +0.2% | +0.1% | +0.2% | +0.1% | +0.0% | -0.1% | +0.2% | -0.1% | -0.1% | -0.3% | +0.0% | -0.3% | -0.9% | +0.0% | +0.1% |
| YoY Change | — | — | — | — | -1.2% | +0.2% | +1.0% | +0.8% | +0.7% | +0.5% | +0.3% | +0.3% | +0.1% | -0.0% | -0.3% | -0.5% | -0.7% | -1.5% | -1.1% | -1.1% |
Range254M – 259.1M
CAGR-0.4%
Avg YoY Growth-0.2%
Median YoY Growth+0.0%
Current Streak2 quarters growth
Common Stock, Shares, Outstanding at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's common stock, shares, outstanding?
- Vertex Pharmaceuticals (VRTX) reported common stock, shares, outstanding of 254.2M in Q1 2026.
- How has Vertex Pharmaceuticals's common stock, shares, outstanding changed year-over-year?
- Vertex Pharmaceuticals's common stock, shares, outstanding decreased by 1.1% year-over-year, from 257M to 254.2M.
- What is the long-term trend for Vertex Pharmaceuticals's common stock, shares, outstanding?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's common stock, shares, outstanding has grown at a -0.5% compound annual growth rate (CAGR), from 259.9M to 254M.
- What does common stock, shares, outstanding mean?
- The total number of shares of common stock currently held by all shareholders.